New blood test combined with image-based prostate cancer screening reduces harm and costs
The combination of a novel blood test and magnetic resonance imaging (MRI) can reduce overdiagnosis of low-risk cancers as well as societal costs in prostate cancer screening, according to a cost-effectiveness study from ...
Jan 28, 2022
0
5
